Trial commencement19 May 2025 10:06
I’m as keen as anyone for the trial to get started but expecting it to be today based on where the Leandra was going to be was optimistic . Given that Jason’s new role starts in a couple of weeks , I imagine that this transition is to make sure there’s laser focus on the trial when it starts , which is likely to be then. Remember that the RNS says “Jason will focus on accelerating the development and deployment of the Company's core technologies, including MSAR®, bioMSAR™ and bioMSAR™ Zero.
In particular, he will take full ownership of the ongoing commercial trials and associated technical programmes and partnerships which are of critical importance for the commercial evolution of the Company. ”